Analysis of Dispensing Errors Made by First-Year Pharmacy Students in a Virtual Dispensing Assessment
Abstract
:1. Introduction
2. Materials and Methods
2.1. Research Participants
2.2. Assessment Design
2.3. Data Collection
2.4. Data Analysis
2.4.1. Quantitative Data Analysis
2.4.2. Qualitative Data Analysis
2.4.3. Harm Associated with Medication Error Classification
3. Results
3.1. Percentage Student Errors
3.1.1. Categorization of Potential Harm
3.1.2. Route of Administration
3.1.3. Drug Formulation
3.1.4. Ancillary Labels
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Pharmaceutical Society of Australia. Dispensing Practice Guidelines. 2019. Available online: https://my.psa.org.au/s/article/Dispensing-Practice-Guidelines (accessed on 17 March 2021).
- Nebeker, J.R.; Barach, P.; Samore, M.H. Clarifying adverse drug events: A clinician’s guide to terminology, documentation, and reporting. Ann. Intern. Med. 2004, 140, 795–801. [Google Scholar] [CrossRef] [PubMed]
- Australian Government—Department of Health. PBS Expenditure and Prescriptions Report 1 July 2019 to 30 June 2020; 17 December 2020. Available online: https://www.pbs.gov.au/info/statistics/expenditure-prescriptions/pb-expenditure-and-prescriptions-report-1-july-2019 (accessed on 8 March 2021).
- James, K.L.; Barlow, D.; McArtney, R.; Hiom, S.; Roberts, D.; Whittlesea, C. Incidence, type and causes of dispensing errors: A review of the literature. Int. J. Pharm. Pract. 2009, 17, 9–30. [Google Scholar] [CrossRef] [PubMed]
- Darbishire, P.L.; Zhao, J.C.; Sodhi, A.; Anderson, C.M. Student observations of medication error reporting practices in community pharmacy settings. Res. Soc. Adm. Pharm. 2019, 15, 902–906. [Google Scholar] [CrossRef] [PubMed]
- Koster, E.S.; Walgers, J.C.; Van Grinsven, M.C.; Winters, N.A.; Bouvy, M.L. Adherence to national recommendations for safe methotrexate dispensing in community pharmacies. J. Manag. Care Pharm. 2014, 20, 194–200. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tariq, R.A.; Vashisht, R.; Sinha, A.; Scherbak, Y. Medication Dispensing Errors and Prevention; StatPearls: Treasure Island, FL, USA, 2020. [Google Scholar]
- Costelloe, M.T. MyDispense: Lessons from global collaboration in developing a pharmacy educational simulation tool. Innov. Pharm. 2017, 8. [Google Scholar] [CrossRef]
- Ambroziak, K.; Ibrahim, N.; Marshall, V.D.; Kelling, S.E. Virtual simulation to personalize student learning in a required pharmacy course. Curr. Pharm. Teach. Learn. 2018, 10, 750–756. [Google Scholar] [CrossRef] [PubMed]
- Atayee, R.S.; Awdishu, L.; Namba, J. Using simulation to improve first-year pharmacy students’ ability to identify medication errors involving the Top 100 prescription medications. Am. J. Pharm. Educ. 2016, 80, 86. [Google Scholar] [CrossRef] [Green Version]
- McDowell, J.; Styles, K.; Sewell, K.; Trinder, P.; Marriott, J.; Maher, S.; Naidu, S. A simulated learning environment for teaching medicine dispensing skills. Am. J. Pharm. Educ. 2016, 80, 11. [Google Scholar] [CrossRef] [Green Version]
- Shin, J.; Tabatabai, D.; Boscardin, C.; Ferrone, M.; Brock, T. Integration of a community pharmacy simulation program into a therapeutics course. Am. J. Pharm. Educ. 2018, 82, 6189. [Google Scholar] [CrossRef] [PubMed]
- Gates, P.J.; Baysari, M.T.; Mumford, V.; Raban, M.Z.; Westbrook, J.I. Standardising the classification of harm associated with medication errors: The harm associated with medication error classification (HAMEC). Drug Saf. 2019, 42, 931–939. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mihas, P.; Odum Institute. Learn to Build a Codebook for a Generic Qualitative Study; SAGE Publications, Limited: London, UK, 2019. [Google Scholar]
- Fonteyn, M.E.; Vettese, M.; Lancaster, D.R.; Bauer-Wu, S. Developing a codebook to guide content analysis of expressive writing transcripts. Appl. Nurs. Res. 2008, 21, 165–168. [Google Scholar] [CrossRef] [PubMed]
- Australian Medicines Handbook. 2020. Available online: https://amhonline.amh.net.au (accessed on 8 March 2021).
- MIMS Online. 2020. Available online: https://www.mimsonline.com.au (accessed on 8 March 2021).
- eTG Complete. 2020. Available online: https://tgldcdp.tg.org.au/etgcomplete (accessed on 8 March 2021).
- Loke, Y.C.; Royal Women’s Hospital (Melbourne Vic.); Pharmacy Department. Women’s Pregnancy and Breastfeeding Medicines Guide: A Guide for Healthcare Professionals. Available online: https://thewomenspbmg.org.au (accessed on 8 March 2021).
- Pharmaceutical Society of Australia. Australian Pharmaceutical Formulary and Handbook: The Everyday Guide to Pharmacy Practice, 24th ed.; Pharmaceutical Society of Australia: Deakin West, ACT, Australia, 2018; Volume VI, p. 682. [Google Scholar]
- Aldhwaihi, K.; Umaru, N.; Pezzolesi, C.; Schifano, F. A systematic review of the nature of dispensing errors in hospital pharmacies. Integr. Pharm. Res. Pract. 2016, 5, 1–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Abdel-Qader, D.H.; Al Meslamani, A.Z.; Lewis, P.J.; Hamadi, S. Incidence, nature, severity, and causes of dispensing errors in community pharmacies in Jordan. Int. J. Clin. Pharm. 2021, 43, 165–173. [Google Scholar] [CrossRef] [PubMed]
- James, K.L.; Barlow, D.; Burfield, R.; Hiom, S.; Roberts, D.; Whittlesea, C. Unprevented or prevented dispensing incidents: Which outcome to use in dispensing error research? Int. J. Pharm. Pract. 2011, 19, 36–50. [Google Scholar] [CrossRef] [PubMed]
- Smith, J.; Cavell, G. Building a Safer NHS for Patients: Improving Medication Safety; Department of Health; Crown: London, UK, 2004; p. 180. [Google Scholar]
Stratification of Harm | Degree of Harm | Description |
---|---|---|
0 | None | No potential for patient harm, nor any change in patient monitoring, level or length of care required |
1 | Minor | Potential for minor, non-life threatening, temporary harm that may or may not require patient monitoring. There may or may not be minimal increase in length of care (<1 day) |
2 | Moderate | Potential for minor, non-life threatening, temporary harm that requires patient monitoring. There may or may not be minimal increase in length of care (<1 day) |
3 | Serious | Potential for major, non-life threatening, temporary harm or minor permanent harm that would require a high level of care such as the administration of an antidote. An increase in the length of care of ≥1 day is expected. |
4 | Severe | Potential for life-threatening or mortal harm or major permanent harm that would require a high level of care such as the administration of an antidote or transfer to intensive care. A substantial increase in the length of care of >1 day is expected. |
Medication Class % of students, (Harm) | |||||||
---|---|---|---|---|---|---|---|
NSAID | BZ | Opioid | Eye Drops | ACEi | Abx | HRT | |
Label Directions | |||||||
Route | 35%, (1) | 0.2%, (1) | 2.5%, (1) | 5.5%, (1) | 0.5%, (1) | 0.5%, (1) | 3.0%, (1) |
Quantity | 1.1%, (4) | 0.2%, (4) | 0.5%, (4) | 0.5%, (4) | 0.2%, (4) | 0%, (4) | 1.2%, (4) |
Frequency | 4.4%, (4) | 10.4%, (4) | 1.6%, (4) | 1.4%, (4) | 0%, (4) | 1.2%, (4) | 4.4%, (4) |
Formulation | 11.3%, (0) | 1.9%, (0) | 0.7%, (1) | 0.2%, (1) | 7.8%, (0) | 1.4%, (1) | |
Duration | 1.7%, (1) | 0.4%, (3) | 32.6%, (1) | ||||
Special Instructions | 1.8%, (1) | 11%, (0) | 0.7%, (4) | 2.9%, (1) | 10, 19, 21%, (1, 4, 4) | ||
Ancillary labels * | 6.4, 4.4%, (0, 1) | 0.7%, (4) | 3.2, 1.4%, (1, 4) | 14.3, 14.1%, (0, 1) | 9.8, 3.4, 0.4%, (0, 1, 3) | 5.0%, (1) | 22.0%, (0) |
Label | Cautionary Advice |
---|---|
A | SWALLOW WHOLE Do not crush or chew |
K | FOR EXTERNAL USE ONLY |
1/1a | This medicine may cause DROWSINESS and may increase the effects of alcohol. If affected, do not drive a motor vehicle or operate machinery. This preparation is to aid sleep. Drowsiness may continue the following day. If affected, do not drive or operate machinery. Avoid alcohol. |
3a/3b | Take on an empty stomach at least half an hour before meals and at bedtime Take on an empty stomach at least half an hour before food or two hours after food |
7b | Discard… days after opening. Date opened / / |
10a | Do not take more than one aspirin tablet or capsule each day while being treated with this medicine. |
11 | DO NOT TAKE POTASSIUM while being treated with this medicine unless advised by your doctor |
12 | This medicine may affect mental alertness and/or coordination. If affected, do not drive a motor vehicle or operate machinery. |
16 | This medicine may cause dizziness especially when you stand up quickly. Ask your doctor or pharmacist for advice. |
18 | Avoid eating grapefruit or drinking grapefruit juice while being treated with this medicine. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chuang, S.; Grieve, K.L.; Mak, V. Analysis of Dispensing Errors Made by First-Year Pharmacy Students in a Virtual Dispensing Assessment. Pharmacy 2021, 9, 65. https://doi.org/10.3390/pharmacy9010065
Chuang S, Grieve KL, Mak V. Analysis of Dispensing Errors Made by First-Year Pharmacy Students in a Virtual Dispensing Assessment. Pharmacy. 2021; 9(1):65. https://doi.org/10.3390/pharmacy9010065
Chicago/Turabian StyleChuang, Sara, Kate Lorraine Grieve, and Vivienne Mak. 2021. "Analysis of Dispensing Errors Made by First-Year Pharmacy Students in a Virtual Dispensing Assessment" Pharmacy 9, no. 1: 65. https://doi.org/10.3390/pharmacy9010065
APA StyleChuang, S., Grieve, K. L., & Mak, V. (2021). Analysis of Dispensing Errors Made by First-Year Pharmacy Students in a Virtual Dispensing Assessment. Pharmacy, 9(1), 65. https://doi.org/10.3390/pharmacy9010065